Candriam S.C.A. - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 136 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 12.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$3,026,000
-31.5%
1,653,9880.0%0.02%
-16.7%
Q1 2022$4,416,000
-42.1%
1,653,988
-6.1%
0.03%
-38.8%
Q4 2021$7,624,000
-54.7%
1,760,922
-46.7%
0.05%
-57.0%
Q3 2021$16,826,000
+14.2%
3,305,940
+42.0%
0.11%
+12.9%
Q2 2021$14,739,000
+1473800.0%
2,328,353
+1594662.3%
0.10%
Q1 2021$1,000
-100.0%
146
-100.0%
0.00%
-100.0%
Q1 2020$6,021,000
-2.2%
741,191
+0.0%
0.07%
+1.5%
Q4 2019$6,159,000
+21.3%
741,144
+7.8%
0.07%
-1.5%
Q3 2019$5,076,000
-33.9%
687,8330.0%0.07%
-30.2%
Q2 2019$7,684,000
+6.9%
687,833
+2.8%
0.10%
+4.3%
Q1 2019$7,190,000
-3.0%
668,833
+36.2%
0.09%
-19.3%
Q4 2018$7,414,000
+2.1%
490,988
+25.0%
0.11%
+17.5%
Q3 2018$7,265,000
+76.4%
392,727
+118.0%
0.10%
+49.2%
Q2 2018$4,118,000
+253.2%
180,127
+339.3%
0.06%
+225.0%
Q1 2018$1,166,000
-37.9%
41,000
-53.9%
0.02%
-39.4%
Q4 2017$1,879,000
-37.3%
89,000
-46.1%
0.03%
-36.5%
Q3 2017$2,998,000
-0.8%
165,000
-15.4%
0.05%
-8.8%
Q2 2017$3,023,000
-10.2%
195,0000.0%0.06%
-12.3%
Q1 2017$3,368,000
+97.8%
195,000
+25.8%
0.06%
+66.7%
Q4 2016$1,703,000
-29.9%
155,0000.0%0.04%
-32.8%
Q3 2016$2,430,000
+255.3%
155,000
+131.3%
0.06%
+222.2%
Q2 2016$684,000
+26.9%
67,000
+59.5%
0.02%
+38.5%
Q1 2016$539,000
+157.9%
42,000
+320.0%
0.01%
+116.7%
Q4 2015$209,00010,0000.01%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Burrage Capital Management LLC 476,110$3,956,0002.65%
MPM BioImpact LLC 855,437$7,109,0002.52%
Exane Asset Management 87,876$730,250,0000.90%
Congress Park Capital LLC 94,661$787,0000.58%
Perceptive Advisors 3,253,923$27,040,0000.54%
BVF INC/IL 766,148$6,367,0000.48%
RTW INVESTMENTS, LP 1,039,593$8,639,0000.33%
EcoR1 Capital, LLC 410,000$3,407,0000.31%
DAFNA Capital Management LLC 100,000$831,0000.28%
HARBOURVEST PARTNERS LLC 79,193$658,0000.27%
View complete list of CYTOMX THERAPEUTICS INC shareholders